Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer
NCT04338438
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
37
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Interventions
DRUG:
Apatinib Mesylate tablets combined with S-1 capsules
Sponsor
Beijing Friendship Hospital